Colorcon Inc.
Colorcon
Colorcon is the undisputed global leader in pharmaceutical film coating systems and specialty excipients, headquartered in Harleysville, Pennsylvania, USA. Founded in 1961, the privately-held company generates estimated annual revenue of $750 million and operates 20+ technical service laboratories worldwide, employing 1,300+ people. Its Opadry® brand is the gold standard for oral solid dosage form coating, used in tens of thousands of pharmaceutical products globally.
Strengths: Near-monopoly market share in pharmaceutical film coating systems with the Opadry® brand platform; unparalleled technical service network — 20+ laboratories providing local formulation support and co-development; extraordinary customer switching costs due to regulatory lock-in of coating formulations in drug approval filings; continuous innovation in enteric coatings, natural color alternatives, and controlled-release technologies; Berwind Group backing providing financial stability and patient capital for long-term R&D.
Weaknesses: single-category concentration — coating systems dominate revenue with limited diversification into other excipient categories; modest absolute revenue (~$750M) compared to diversified chemical giants; limited exposure to high-growth biologic drug delivery systems and parenteral excipients.Read MoreShow Less
Strengths: Near-monopoly market share in pharmaceutical film coating systems with the Opadry® brand platform; unparalleled technical service network — 20+ laboratories providing local formulation support and co-development; extraordinary customer switching costs due to regulatory lock-in of coating formulations in drug approval filings; continuous innovation in enteric coatings, natural color alternatives, and controlled-release technologies; Berwind Group backing providing financial stability and patient capital for long-term R&D.
Weaknesses: single-category concentration — coating systems dominate revenue with limited diversification into other excipient categories; modest absolute revenue (~$750M) compared to diversified chemical giants; limited exposure to high-growth biologic drug delivery systems and parenteral excipients.
In the press
All coverage →5 latest headlines21- SPI Pharma and Colorcon announce strategic global partnership - Manufacturing Chemistmanufacturingchemist.com2026-10-06
- SPI Pharma, Colorcon Forge Partner to Expand Oral Drug Delivery Solutions - Contract Pharmawww.contractpharma.com2026-10-01
- University of Mississippi and Colorcon build AI database for 3D printed drugs - VoxelMatterswww.voxelmatters.com2026-09-16
- Colorcon Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labswww.reveliolabs.com2026-07-30
- Moisture-Protective Nutraceutical Closures: The Colorcon OneLock Has an All-in-One Design - Trend Hunterwww.trendhunter.com2026-04-18
• Opadry® complete film coating systems for immediate-release tablets
• Opadry® II high-productivity coating systems
• Opaglos® high-gloss coating systems
Functional Coatings — High-Value Segment
• Acryl-EZE® enteric coating systems
• Surelease® ethylcellulose dispersion for sustained release
• Nutrateric® nutritional coating for taste masking
Specialty Excipients & Cores — Growing Portfolio
• Suglets® sugar spheres for multi-particulate drug delivery
• StarCap® and StarLac® co-processed excipients
Quick Facts
Headquarters
Harleysville, Pennsylvania, United States
Founded
1961
Employees
1,300+
Revenue
~$750 M (2025 est.)
Factories
20+ technical service laboratories and dedicated cGMP coating powder manufacturing facilities globally
Presence
Direct operations in 25 countries
Listing
Private (Berwind subsidiary)Categories
Related
Similar listed companies
- Eli Lilly and Company· $1.1 T
- Johnson & Johnson (J&J)· $616 B
- Allergan Aesthetics· $504 B
- AbbVie Inc.· $504 B
- F. Hoffmann-La Roche AG· $372 B
- Merck Animal Health· $360 B
Data Sources & Methodology
This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.
VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.
Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.
Key references: Official Website , Colorcon Official Website
PitchBook — Colorcon Company Profile
Mordor Intelligence — Pharmaceutical Excipients Market